NAACCR talks are webinars on topics of interest to the NAACCR Community presented by members of the NAACCR Community. Topics include cancer surveillance, central registry operations, new technology, upcoming changes, and much more! Registration is free, but you must login using your MyNAACCR username and password. 

Live NAACCR Talks

There are no products which match your search criteria.

On-Demand NAACCR Talks

  • Recorded On: 02/26/2024

    Adolescent and Young Adult (AYA) Oncology: The insights gained from the Malignant Germ Cell International Consortium (MaGIC).

    Dr. A. Lindsay Frazier, MD

    One of the most common adolescent and young adult (AYA) cancers are the cell tumors (GCTs), however no significant change has happened to GCTs treatments protocols in the last decades. The Malignant Germ Cell International Consortium (MaGIC) brings together the world’s leading experts in germ cell tumors (GCTs), from across the spectrum of cancer research, with the shared goal of developing more effective treatments for GCTs through scientific inquiry. As the lead of the Malignant Germ Cell Tumor International Consortium, Dr Lindsay will discuss AYA Oncology and share important lessons learned in the field of GCT research.

     

    Forecasting for Accurate Procurement of Pediatric Chemotherapies.

    Dr. Shrivastava, MD, MPH

    Forecasting the cost and quantities of pediatric chemotherapies is an essential part of ensuring a reliable supply of essential medicines for the care of children with cancer. Dr. Shrivastava will describe the importance of access to accurate registry data and its relevance today amongst several critical drug shortages. 

    Dr. A Lindsay Frazier, MD, ScM

    Professor of Pediatrics

    Harvard Medical School

    Dr. Frazier received her MD from Dartmouth Medical School in 1984, followed by a pediatric residency at Children’s Hospital Boston and a pediatric hematology-oncology fellowship at DFCI, where she joined the faculty in 1990. She received an ScM from Harvard School of Public Health in 1993. In clinical practice, she concentrates on germ cell tumors, while her epidemiologic research primarily focuses on colorectal cancer screening and prevention.

    Dr. Nitin Shrivastava, MD, MPH

    Pediatric Hematology /Oncology Fellow

    Dana-Farber/Bostin Children's Cancer and Blood Disorders Center

    Dr. Nitin Shrivastava is a pediatric hematology-oncology fellow in his final year of training at Dana-Farber Cancer Institute/Boston Children’s Hospital. He received his medical degree from the University of Massachusetts Medical School and completed a Master of Public Health at the Harvard T.H. Chan School of Public Health. He completed his residency in general pediatrics at Boston Children’s Hospital. In addition to his clinical work, Nitin has been focused on improving access to pediatric cancer care globally. During his fellowship, he has worked to improve forecasting the amounts and costs of chemotherapy forecasting for pediatric patients in the U.S., Canada, and internationally under the mentorship of Dr. Lindsay Frazier.

  • Recorded On: 01/29/2024

    Next-Gen Cancer Registry: Using AI to Automate Cancer Registry Operations 

    Dr. Jonathan Simkin, Scientific Director BC Cancer Registry

    Dr. Lovedeep Gondara, Research Scientist, Provincial Health Services Authority

    This talk examines the practical implications of artificial intelligence (AI) on cancer registries, focusing on the BC Cancer Registry. Beginning with an analysis of early rule-based approaches in Natural Language Processing (NLP) for cancer coding, we assess both the advantages and limitations of this methodology in the real-world setting. The presentation then explores the impact of these tools on cancer coding and operational efficiency in registries. This talk also demonstrates the BC Cancer Registry's NLP pipelines, presenting their performance metrics across diverse tasks, including case finding from pathology reports and autocoding capabilities that streamline the extraction of critical registry data fields. Finally, this talk will provide insights into how AI-driven automation expedites data processing and strategically addresses resource challenges, offering a pragmatic solution for cancer registry operations. 

    Practical Applications of Natural Language Processing and Machine Learning to Improve Efficiencies and Enhance Central Cancer Registries 

    Dr. Eric Durbin, Director, Kentucky Cancer Registry

    This presentation will cover several examples of efforts in natural language processing and machine learning that are designed to improve efficiencies in registry operations and enhance registry data with content automatically derived from clinical and other documents. 

    ChatGPT, Where Would I Start? 

    Dr. Francis Boscoe, Pumphandle, LLC

    This talk is an introduction to ChatGPT and similar generative AI tools. It will cover the basics of what these tools are, how we might use them, and some of the limitations.

    Jonathan Simkin, PhD, MPH

    Scientific Director

    British Columbia Cancer Registry, BC Cancer, Provincial Health Services Authority

    Dr. Jonathan Simkin, PhD MPH, Scientific Director of the BC Cancer Registry and Co-Chair of the Canadian Council of Cancer Registries, holds a PhD and MPH from the University of British Columbia. His research expertise spans geospatial methods in cancer surveillance, population oncology research, and the application of deep learning methods in cancer surveillance. Dr. Simkin has a ten-year tenure in cancer registry and surveillance settings, including roles as a Cancer Epidemiologist at the Yukon Government and more recently as the Scientific Director of the British BC Cancer Registry at BC Cancer, which he has led since 2019. Dr. Simkin's leadership in implementing cutting-edge technology at the BC Cancer Registry is driving transformative change in cancer data management, ensuring improved efficiency, timeliness, and data quality to support cancer care and research. 

    Lovedeep Gondara, PhD, MS

    Reasearch Scientist

    Provincial Health Services Authority

    Dr. Gondara is a Research Scientist, with specialization in machine learning and biostatistics at the Provincial Health Services Authority (PHSA). His research focus encompasses several areas within machine learning and biostatistics, including natural language processing, multimodal learning, privacy-preserving machine learning, flexible survival regression models, Bayesian statistics, and their integration into the healthcare domain. In his previous role as a biostatistician, Dr. Gondara was responsible for the design and analysis of multiple clinical trials spanning multiple disease domains, such as breast cancer, brain and CNS tumors, cervical cancer screening, etc.

    Eric B Durbin, DrPH, MS

    Director

    Kentucky Cancer Registry

    Eric B. Durbin, DrPH, MS, is an Assistant Professor in the Division of Biomedical Informatics at the University of Kentucky (UK) College of Medicine.  He serves as the Director of the Kentucky Cancer Registry (KCR) and the Director of the Cancer Research Informatics Shared Resource Facility at the UK Markey Cancer Center.  He has over 30 years of experience in population-based cancer surveillance and informatics support for basic, clinical and translational cancer research.  His research interests include precision cancer surveillance, pathology informatics, machine learning methods and cancer epidemiology.
     
    Dr. Durbin’s current research is focused on the integration of multi–omics data to support decision-making in precision medicine and cancer prevention and control, informatics methods to support pediatric and young adult cancer patient surveillance and research and the development of machine learning methods to derive clinical biomarkers from narrative electronic pathology reports and digital slide images.

    Francis P Boscoe, PhD

    Founder

    Pumphandle

    Frank Boscoe worked at the New York State Department of Health from 1999 to 2019, nearly all of that time with the New York State Cancer Registry, before starting his own consulting business in 2019.

  • Recorded On: 11/06/2023

    This two-part series is presented by CDC colleagues who are on the forefront of a number of initiatives in the rapidly developing area of public health interoperability. This educational series was presented at the NAACCR annual conference in June 2023 and, due to popular demand, is being offered as a "replay" for the entire NAACCR community.  These two sessions will provide an overview of key interoperability terms and an update on current initiatives that will impact public health and cancer surveillance in particular. These initiatives are intended to improve health data exchange and quality across healthcare. Topics will include benefits and potential implications for registries. There will be time for questions and answers throughout both sessions. 

    Sean Porter, MSHI

    Health Scientist (Informatics)

    CDC

    Sean Porter MSHI, Health Scientist (Informatics), leads the Physician Reporting module development team for eMaRC Plus and the Cancer Report Validator, which support accurate reporting from EHRs. Sean also leads an internal CDC workgroup to determine the minimum data set requirements to improve and speed up the reporting of cancer incidences and serves on the NAACCR Minimum Data Set Task Force.

    Caitlin Kennedy, MSPH

    Health Scientist (Informatics)

    CDC

    Caitlin Kennedy, MSPH, Health Scientist (Informatics), provides expertise on projects that facilitate EHR interoperability, the CDC’s Data Modernization Initiative in the context of cancer surveillance, and she coordinates on solutions that standardize the collection and exchange of cancer data, such as cancer content HL7 FHIR IGs. 

    Kasey Diebold, MS

    Health Informaticist

    CDC

    Kasey Diebold, MS, Health Informaticist, has spent the past decade focused on the intersection of epidemiology and data science, defining and implementing best practices for surveillance epidemiology, rapid response systems, and data modernization of public health systems.

    Sandy Jones

    Public Health Advisor

    CDC

    Sandy Jones is a Public Health Advisor with the Cancer Surveillance Branch, Division of Cancer Prevention and Control at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA.  She coordinates the implementation of electronic reporting of cancer pathology and biomarker data from national and regional laboratories to state cancer registries using the NAACCR Volume V and CAP Cancer Protocols and Templates. Mrs. Jones serves as Co-Chair of the NAACCR Volume V Revision Task Force that is charged with updating the implementation guide for laboratory reporting of cancer pathology and biomarker data. She has been with the CDC since 1989 and has spent most of that time providing expertise in the areas of data management, computer programming, informatics, and network administration for cancer prevention and control and environmental health programs.

    Joseph Rogers, MS

    Team Lead for Informatics, Data Science and Applications Team

    CDC

    Joseph D. Rogers received his B.S. and M.S. in Biology/Chemistry and Information Management respectively from Arizona State University (ASU).  He worked in Arizona for the Maricopa County Health Department as a project manager and data analyst before joining CDC in 1991 (first as a contractor and then as a federal employee in 1997).  During Mr. Rogers’ contracting years at CDC, he worked as a systems analyst on information technology projects, as a project manager, and as a data manager within the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP).  When Mr. Rogers joined the Centers for Disease Control and Prevention (CDC) as a federal employee, he initially worked for the Agency for Toxic Substances and Disease Registry (ATSDR) as data manager and later joined the Division of Cancer Prevention and Control (DCPC)/Cancer Surveillance Branch (CSB) in 1998 as the Team Lead for the IDSAT Team

  • Recorded On: 11/13/2023

    The NAACCR Professional Development Steering Committee Upkeep Task Force revised the Oncology Data Specialist Training Guide. This presentation will review the revisions and the goals of the guide.

    Constance "Connie" Boone, BA, AAS, CTR

    Senior Clinical Data Partner

    Prisma Health

    Connie has been a CTR since 2018 working in a Multi facility Academic Enterprise followed by working as the Quality Assurance Manager & Education/Training Coordinator for South Carolina. She is currently the cancer registry manager of a multi-facility health system in SC.  Recipient of the April Fritz Award in 2020, NAACCR Future Leaders Award in 2022.  She is also the current president of the SC Cancer Registrars Association.


  • Recorded On: 10/23/2023

    This webinar will introduce Vesta, a software for visualization and exploratory space-time analysis and modeling.  Developed with funding from the National Cancer Institute and the National Institute of Environmental Health Sciences, Vesta is designed to accelerate visualization, hypothesis generation, and modeling of complex, multivariate datasets that typify health-environment relationships.  

    This webinar will also demonstrate four applications of using Vesta to answer public health questions including hypothesis generation (identification of spatial patterns for cervical mortality that account for ethnicity and poverty, visualization of late-stage breast cancer incidence) and hypothesis testing (Flint water lead levels, late-stage breast cancer incidence). 

    Pierre Goovaerts, PhD

    Chief Scientist

    BioMedware

    Pierre Goovaerts (PhD) is Chief Scientist at BioMedware. Prior to joining BioMedware in 2002,Dr. Goovaerts studied at the Catholic University of Louvain-la-Neuve (Belgium)and at Stanford University. He spent five years on the Faculty at theUniversity of Michigan, Civil and Environmental Engineering department. He hastaught geostatistics workshops on six continents, which are attended byacademics, consultants and government employees, and was the 2013 International Association forMathematical Geosciences Distinguished Lecturer. Dr. Goovaerts has authored more than160 refereed papers in the field of theoretical and applied geostatistics,written the reference textbook in the field, and he is a reviewer for50 international journals. He is a consultant on environmental projects dealingwith the characterization of air, soil and water pollution and its impact onhuman health. Since 2006, Dr. Goovaerts has been a Courtesy Associate Professorat the University of Florida, Soil and Water Science Department. (See also Google Scholar and ResearchGate.)

    Geoffrey M. Jacquez, MS, PhD

    President

    BioMedware

    Geoffrey M. Jacquez (MS, PhD) is President of BioMedware, Adjunct Professor of Environmental Healthat The University of Michigan, and former Professor of Geography, StateUniversity of New York at Buffalo. Prior to founding BioMedware in 1990, Dr.Jacquez was a Research Associate at the Stony Brook Research Foundation at theState University of New York. Dr. Jacquez has led several successful softwaredevelopment efforts in the area of spatial and space-time data analysis,simulation, and modeling. He is internationally recognized in the field of GISand health, and holds four patents with one pending for unique softwareinnovations he conceived and developed. He is a founding member of theeditorial board of the journal Spatial and Spatio-temporal Epidemiology, and was recently co-science directorof crcsiAustralia health program (See also Google Scholar and ResearchGate.)